Pulmonary arterial hypertension: pathogenesis and clinical management

T Thenappan, ML Ormiston, JJ Ryan, SL Archer - Bmj, 2018 - bmj.com
Pulmonary hypertension is defined as a resting mean pulmonary artery pressure of 25 mm
Hg or above. This review deals with pulmonary arterial hypertension (PAH), a type of …

Cellular and molecular pathobiology of pulmonary arterial hypertension

M Humbert, NW Morrell, SL Archer… - Journal of the American …, 2004 - jacc.org
Pulmonary arterial hypertension (PAH) has a multifactorial pathobiology. Vasoconstriction,
remodeling of the pulmonary vessel wall, and thrombosis contribute to increased pulmonary …

Pediatric pulmonary hypertension: guidelines from the American heart association and American thoracic society

SH Abman, G Hansmann, SL Archer, DD Ivy, I Adatia… - Circulation, 2015 - Am Heart Assoc
Pulmonary hypertension is associated with diverse cardiac, pulmonary, and systemic
diseases in neonates, infants, and older children and contributes to significant morbidity and …

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European …

N Galiè, MM Hoeper, M Humbert, A Torbicki… - European heart …, 2009 - academic.oup.com
Thus, the task of writing Guidelines or Expert Consensus documents covers not only the
integration of the most recent research, but also the creation of educational tools and …

Treatment of pulmonary arterial hypertension

M Humbert, O Sitbon… - New England Journal of …, 2004 - Mass Medical Soc
Pulmonary arterial hypertension, which is characterized by vascular proliferation and
remodeling of small pulmonary vessels, leads to a progressive increase in pulmonary …

Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the …

N Galie, A Torbicki, R Barst, P Dartevelle… - European heart …, 2004 - academic.oup.com
Level of Evidence A Data derived from multiple randomised clinical trials or meta-analyses
Level of Evidence B Data derived from a single randomised clinical trial or large non …

Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond

HA Ghofrani, IH Osterloh, F Grimminger - Nature reviews Drug …, 2006 - nature.com
In less than 20 years, the first selective type 5 phosphodiesterase inhibitor, sildenafil, has
evolved from a potential anti-angina drug to an on-demand oral treatment for erectile …

Comprehensive invasive and noninvasive approach to the right ventricle–pulmonary circulation unit: state of the art and clinical and research implications

HC Champion, ED Michelakis, PM Hassoun - Circulation, 2009 - Am Heart Assoc
markers such as right atrial pressure, cardiac output, and mean PAP. 8 Importantly, this
procedure has been shown to be safe, with no deaths reported in the National Institutes of …

Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics

EJ Tsai, DA Kass - Pharmacology & therapeutics, 2009 - Elsevier
Cyclic guanosine 3', 5'-monophosphate (cGMP) mediates a wide spectrum of physiologic
processes in multiple cell types within the cardiovascular system. Dysfunctional signaling at …

Acute oxygen-sensing mechanisms

EK Weir, J López-Barneo, KJ Buckler… - New England Journal …, 2005 - Mass Medical Soc
This review discusses recent advances in the understanding of the ways in which different
organs detect and respond to acute changes in oxygen tension. A group of specialized …